Evidence map›Paper›PMID 35908057›Full record

ArticleJournal of nanobiotechnology2022

Biodegradable and biocompatible exceedingly small magnetic iron oxide nanoparticles for T

Xuanyi Lu, Huimin Zhou, Zhiyu Liang, Jie Feng, Yudie Lu, Lin Huang, Xiaozhong Qiu, Yikai Xu, Zheyu Shen

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Magnetic nanoparticles for cancer theranostics.Biomedical physics & engineering express · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xuanyi Lu *Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Guangzhou, 510515, Guangdong, China.
Huimin Zhou *Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, School of Basic Medical Sciences, Southern Medical University, 1023 Shatai South Road, Guangzhou, 510515, Guangdong, China.
Zhiyu LiangMedical Imaging Center, Nanfang Hospital, School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Guangzhou, 510515, Guangdong, China.
Jie FengMedical Imaging Center, Nanfang Hospital, School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Guangzhou, 510515, Guangdong, China.
Yudie LuBiomaterials Research Center, School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Guangzhou, 510515, Guangdong, China.
Lin HuangBiomaterials Research Center, School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Guangzhou, 510515, Guangdong, China.
Xiaozhong QiuGuangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, School of Basic Medical Sciences, Southern Medical University, 1023 Shatai South Road, Guangzhou, 510515, Guangdong, China. qqiuxzh@163.com.
Yikai XuMedical Imaging Center, Nanfang Hospital, School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Guangzhou, 510515, Guangdong, China. yikaivip@163.com.
Zheyu ShenBiomaterials Research Center, School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Guangzhou, 510515, Guangdong, China. sz@smu.edu.cn.
Southern Medical University · CNNanfang Hospital · CN

Funding

Guangdong Provincial Natural Science Foundation of China 2021A1515010605Guangzhou Key Research and Development Program of China 202103000094National Natural Science Foundation of China 51761145021Zhejiang Provincial Natural Science Foundation of China LR19E030001
6 · The paper itself

Abstract

Magnetic resonance imaging (MRI) has been widely using in clinical diagnosis, and contrast agents (CAs) can improve the sensitivity MRI. To overcome the problems of commercial Gd chelates-based T

Indexed as

Magnetic Resonance ImagingNeoplasmsAnimalsContrast MediaMagnetic Iron Oxide NanoparticlesMiceTissue DistributionWaterContrast MediaWaterBiodegradableContrast agents (CAs)Exceedingly small magnetic iron oxide nanoparticles (ES-MIONs)Magnetic resonance imaging (MRI)Poly (aspartic acid) (PASP)

Identifiers

PMID35908057
PMCPMC9338602
OpenAlexW4288685262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.